Top quality managementProven track record on highly innovative research projects
Synapse is committed to support research initiatives with an impact on improving the health and quality of life of citizens. In this spirit, Synapse has initiated its Social Programme, which financially supports local initiatives in the biomedical sector with a social impact in the community.
Synapse sponsors ASIMAGA, a Spanish non-profit association created from the concern of families of children affected with the Cri du chat syndrome considered a rare genetic disorder.
This syndrome, also known as chromosome 5p deletion syndrome, 5p− syndrome (“Five P Minus”) or Lejeune’s syndrome, is a rare genetic disorder due to chromosome deletion on chromosome 5. Its name is a French term (cat-cry or call of the cat) referring to the characteristic cat-like cry of affected children. It was first described by Jérôme Lejeune in 1963.The condition affects an estimated 1 in 50,000 live births across all ethnicities.
ASIMAGA was born with the purpose to know the origin and causes of this disease, and the intention to promote actions, activities and projects to improve the quality of life from the perspective of people with this syndrome and their relatives.
With this donation, Synapse aims to contribute to the awareness of the Cri du chat syndrome considered a rare genetic disorder, in the frame of its social commitment as a company specialized in the management of research and development projects in the biomedical sector.
More info at: ASIMAGA
Synapse contributes to promote Paediatric Oncology welfare. Synapse auspices The Enriqueta Villavecchia Private Foundation for Child Oncology, a non-profit organization from Barcelona (Spain), to provide integral care for children and youngsters suffering from cancer and other long-term serious diseases and give support to their families along all the stages in the process.
The main goals of the Foundation are focused on driving progress in Paediatric Oncology and Haematology by promoting research and medical training, as well as offering new welfare proposals, improving quality of life in sick children and youngsters and achieving their full psychosocial integration. Finally, raise social awareness on the reality of child cancer and other long-term serious diseases.
With this donation, Synapse aims to contribute to the awareness Child Oncology in the frame of its social commitment as a company specialized in the management of research and development projects in the biomedical sector, some of them related to cancer disease.
More info at: www.fevillavecchia.es
Synapse sponsors AFASAF, a national non-profit organisation from Barcelona, created by a number of families whose children suffer from Fetal Alcohol Spectrum Disorders (FADS). FASD is a lifelong group of conditions relating to permanent brain damage caused by fetal alcohol exposure. The most severe form of the condition is known as Fetal Alcohol Syndrome (FAS).
The main objectives of the association are to improve the quality of life of the affected people and their families and obtain the official and social recognition of the Syndrome.
With this donation, Synapse aims to contribute to the awareness, recognition and proper diagnostics of the Fetal Alcohol Syndrome in the frame of its social commitment as a company specialized in the management of research and development projects in the biomedical sector. More info at: AFASAF
Synapse auspices Paliaclinic foundation a non-profit organization born out of awareness in the field of palliative care, aiming to address the suffering of patients and family members facing advanced disease and end of life.
The main goal of the foundation is to provide to the patients and their families with all the necessary support so they can experience the final process of the disease in a dignified manner, with the least possible suffering, in the chosen place and with the desired accompaniment. The Paliaclinic Foundation tends to raise awareness among the population and respond to needs and difficulties, with the aim of improving the quality of life of people affected by any disease in advanced stages.
In the frame of its social commitment as a company specialized in the management of research and development projects in the biomedical sector, with this donation, Synapse aims to contribute to the better treatment of terminal patients, and to raise awareness about palliative care. More info at: Paliaclinic Foundation